Global Etoricoxib Intermediate Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 10-Oct-2018
No. of pages: 135

Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely cyclooxygenase-2 and COX-2.

Scope of the Report:

This report focuses on the Etoricoxib Intermediate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Some of the NSAIDs can be used in a single dose to treat various types of pain; it can also be used for post-surgical pains.

The worldwide market for Etoricoxib Intermediate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Bayer

- Novacap

- Abbott

- Pfizer

- Geri-Care

- Perrigo

- Kopran

- Merck

- Sun Pharmaceutical

- GlaxoSmithKline

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- n-House Manufacturing

- Contract Manufacturing Organizations

Market Segment by Applications, can be divided into

- Rheumatoid Arthritis

- Psoriatic Arthritis

- Osteoarthritis

- Ankylosing Spondylitis

- Chronic Low Back Pain

- Acute Pain

- Others

There are 15 Chapters to deeply display the global Etoricoxib Intermediate market.

Chapter 1, to describe Etoricoxib Intermediate Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Etoricoxib Intermediate, with sales, revenue, and price of Etoricoxib Intermediate, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Etoricoxib Intermediate, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Etoricoxib Intermediate market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Etoricoxib Intermediate sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Etoricoxib Intermediate Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Etoricoxib Intermediate Introduction
1.2 Market Analysis by Type
1.2.1 n-House Manufacturing
1.2.2 Contract Manufacturing Organizations
1.3 Market Analysis by Applications
1.3.1 Rheumatoid Arthritis
1.3.2 Psoriatic Arthritis
1.3.3 Osteoarthritis
1.3.4 Ankylosing Spondylitis
1.3.5 Chronic Low Back Pain
1.3.6 Acute Pain
1.3.7 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Etoricoxib Intermediate Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novacap
2.2.1 Business Overview
2.2.2 Etoricoxib Intermediate Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novacap Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Abbott
2.3.1 Business Overview
2.3.2 Etoricoxib Intermediate Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abbott Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Etoricoxib Intermediate Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Geri-Care
2.5.1 Business Overview
2.5.2 Etoricoxib Intermediate Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Geri-Care Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Perrigo
2.6.1 Business Overview
2.6.2 Etoricoxib Intermediate Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Perrigo Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Kopran
2.7.1 Business Overview
2.7.2 Etoricoxib Intermediate Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Kopran Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Merck
2.8.1 Business Overview
2.8.2 Etoricoxib Intermediate Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merck Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sun Pharmaceutical
2.9.1 Business Overview
2.9.2 Etoricoxib Intermediate Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sun Pharmaceutical Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 GlaxoSmithKline
2.10.1 Business Overview
2.10.2 Etoricoxib Intermediate Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GlaxoSmithKline Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Etoricoxib Intermediate Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Etoricoxib Intermediate Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Etoricoxib Intermediate Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Etoricoxib Intermediate Manufacturer Market Share in 2017
3.3.2 Top 6 Etoricoxib Intermediate Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Etoricoxib Intermediate Market Analysis by Regions
4.1 Global Etoricoxib Intermediate Sales, Revenue and Market Share by Regions
4.1.1 Global Etoricoxib Intermediate Sales and Market Share by Regions (2013-2018)
4.1.2 Global Etoricoxib Intermediate Revenue and Market Share by Regions (2013-2018)
4.2 North America Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
4.3 Europe Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
4.5 South America Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
5 North America Etoricoxib Intermediate by Countries
5.1 North America Etoricoxib Intermediate Sales, Revenue and Market Share by Countries
5.1.1 North America Etoricoxib Intermediate Sales and Market Share by Countries (2013-2018)
5.1.2 North America Etoricoxib Intermediate Revenue and Market Share by Countries (2013-2018)
5.2 United States Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
5.3 Canada Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
5.4 Mexico Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
6 Europe Etoricoxib Intermediate by Countries
6.1 Europe Etoricoxib Intermediate Sales, Revenue and Market Share by Countries
6.1.1 Europe Etoricoxib Intermediate Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Etoricoxib Intermediate Revenue and Market Share by Countries (2013-2018)
6.2 Germany Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
6.3 UK Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
6.4 France Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
6.5 Russia Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
6.6 Italy Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
7 Asia-Pacific Etoricoxib Intermediate by Countries
7.1 Asia-Pacific Etoricoxib Intermediate Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Etoricoxib Intermediate Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Etoricoxib Intermediate Revenue and Market Share by Countries (2013-2018)
7.2 China Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
7.3 Japan Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
7.4 Korea Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
7.5 India Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
8 South America Etoricoxib Intermediate by Countries
8.1 South America Etoricoxib Intermediate Sales, Revenue and Market Share by Countries
8.1.1 South America Etoricoxib Intermediate Sales and Market Share by Countries (2013-2018)
8.1.2 South America Etoricoxib Intermediate Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
8.3 Argentina Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
8.4 Colombia Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
9 Middle East and Africa Etoricoxib Intermediate by Countries
9.1 Middle East and Africa Etoricoxib Intermediate Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Etoricoxib Intermediate Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Etoricoxib Intermediate Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
9.3 UAE Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
9.4 Egypt Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
9.5 Nigeria Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
9.6 South Africa Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
10 Global Etoricoxib Intermediate Market Segment by Type
10.1 Global Etoricoxib Intermediate Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Etoricoxib Intermediate Sales and Market Share by Type (2013-2018)
10.1.2 Global Etoricoxib Intermediate Revenue and Market Share by Type (2013-2018)
10.2 n-House Manufacturing Sales Growth and Price
10.2.1 Global n-House Manufacturing Sales Growth (2013-2018)
10.2.2 Global n-House Manufacturing Price (2013-2018)
10.3 Contract Manufacturing Organizations Sales Growth and Price
10.3.1 Global Contract Manufacturing Organizations Sales Growth (2013-2018)
10.3.2 Global Contract Manufacturing Organizations Price (2013-2018)
11 Global Etoricoxib Intermediate Market Segment by Application
11.1 Global Etoricoxib Intermediate Sales Market Share by Application (2013-2018)
11.2 Rheumatoid Arthritis Sales Growth (2013-2018)
11.3 Psoriatic Arthritis Sales Growth (2013-2018)
11.4 Osteoarthritis Sales Growth (2013-2018)
11.5 Ankylosing Spondylitis Sales Growth (2013-2018)
11.6 Chronic Low Back Pain Sales Growth (2013-2018)
11.7 Acute Pain Sales Growth (2013-2018)
11.8 Others Sales Growth (2013-2018)
12 Etoricoxib Intermediate Market Forecast (2018-2023)
12.1 Global Etoricoxib Intermediate Sales, Revenue and Growth Rate (2018-2023)
12.2 Etoricoxib Intermediate Market Forecast by Regions (2018-2023)
12.2.1 North America Etoricoxib Intermediate Market Forecast (2018-2023)
12.2.2 Europe Etoricoxib Intermediate Market Forecast (2018-2023)
12.2.3 Asia-Pacific Etoricoxib Intermediate Market Forecast (2018-2023)
12.2.4 South America Etoricoxib Intermediate Market Forecast (2018-2023)
12.2.5 Middle East and Africa Etoricoxib Intermediate Market Forecast (2018-2023)
12.3 Etoricoxib Intermediate Market Forecast by Type (2018-2023)
12.3.1 Global Etoricoxib Intermediate Sales Forecast by Type (2018-2023)
12.3.2 Global Etoricoxib Intermediate Market Share Forecast by Type (2018-2023)
12.4 Etoricoxib Intermediate Market Forecast by Application (2018-2023)
12.4.1 Global Etoricoxib Intermediate Sales Forecast by Application (2018-2023)
12.4.2 Global Etoricoxib Intermediate Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Etoricoxib Intermediate Picture
Table Product Specifications of Etoricoxib Intermediate
Figure Global Sales Market Share of Etoricoxib Intermediate by Types in 2017
Table Etoricoxib Intermediate Types for Major Manufacturers
Figure n-House Manufacturing Picture
Figure Contract Manufacturing Organizations Picture
Figure Etoricoxib Intermediate Sales Market Share by Applications in 2017
Figure Rheumatoid Arthritis Picture
Figure Psoriatic Arthritis Picture
Figure Osteoarthritis Picture
Figure Ankylosing Spondylitis Picture
Figure Chronic Low Back Pain Picture
Figure Acute Pain Picture
Figure Others Picture
Figure United States Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure France Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure UK Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure China Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure India Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Etoricoxib Intermediate Revenue (Value) and Growth Rate (2013-2023)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Etoricoxib Intermediate Type and Applications
Table Bayer Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novacap Basic Information, Manufacturing Base and Competitors
Table Novacap Etoricoxib Intermediate Type and Applications
Table Novacap Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Etoricoxib Intermediate Type and Applications
Table Abbott Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Etoricoxib Intermediate Type and Applications
Table Pfizer Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Geri-Care Basic Information, Manufacturing Base and Competitors
Table Geri-Care Etoricoxib Intermediate Type and Applications
Table Geri-Care Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Perrigo Basic Information, Manufacturing Base and Competitors
Table Perrigo Etoricoxib Intermediate Type and Applications
Table Perrigo Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kopran Basic Information, Manufacturing Base and Competitors
Table Kopran Etoricoxib Intermediate Type and Applications
Table Kopran Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Etoricoxib Intermediate Type and Applications
Table Merck Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Etoricoxib Intermediate Type and Applications
Table Sun Pharmaceutical Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Etoricoxib Intermediate Type and Applications
Table GlaxoSmithKline Etoricoxib Intermediate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Etoricoxib Intermediate Sales by Manufacturer (2016-2017)
Figure Global Etoricoxib Intermediate Sales Market Share by Manufacturer in 2016
Figure Global Etoricoxib Intermediate Sales Market Share by Manufacturer in 2017
Table Global Etoricoxib Intermediate Revenue by Manufacturer (2016-2017)
Figure Global Etoricoxib Intermediate Revenue Market Share by Manufacturer in 2016
Figure Global Etoricoxib Intermediate Revenue Market Share by Manufacturer in 2017
Figure Top 3 Etoricoxib Intermediate Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Etoricoxib Intermediate Manufacturer (Revenue) Market Share in 2017
Figure Global Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Global Etoricoxib Intermediate Revenue and Growth Rate (2013-2018)
Table Global Etoricoxib Intermediate Sales by Regions (2013-2018)
Table Global Etoricoxib Intermediate Sales Market Share by Regions (2013-2018)
Table Global Etoricoxib Intermediate Revenue by Regions (2013-2018)
Figure Global Etoricoxib Intermediate Revenue Market Share by Regions in 2013
Figure Global Etoricoxib Intermediate Revenue Market Share by Regions in 2017
Figure North America Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Europe Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure South America Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure North America Etoricoxib Intermediate Revenue and Growth Rate (2013-2018)
Table North America Etoricoxib Intermediate Sales by Countries (2013-2018)
Table North America Etoricoxib Intermediate Sales Market Share by Countries (2013-2018)
Figure North America Etoricoxib Intermediate Sales Market Share by Countries in 2013
Figure North America Etoricoxib Intermediate Sales Market Share by Countries in 2017
Table North America Etoricoxib Intermediate Revenue by Countries (2013-2018)
Table North America Etoricoxib Intermediate Revenue Market Share by Countries (2013-2018)
Figure North America Etoricoxib Intermediate Revenue Market Share by Countries in 2013
Figure North America Etoricoxib Intermediate Revenue Market Share by Countries in 2017
Figure United States Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Canada Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Mexico Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Europe Etoricoxib Intermediate Revenue and Growth Rate (2013-2018)
Table Europe Etoricoxib Intermediate Sales by Countries (2013-2018)
Table Europe Etoricoxib Intermediate Sales Market Share by Countries (2013-2018)
Table Europe Etoricoxib Intermediate Revenue by Countries (2013-2018)
Figure Europe Etoricoxib Intermediate Revenue Market Share by Countries in 2016
Figure Europe Etoricoxib Intermediate Revenue Market Share by Countries in 2017
Figure Germany Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure UK Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure France Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Russia Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Italy Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Etoricoxib Intermediate Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Etoricoxib Intermediate Sales by Countries (2013-2018)
Table Asia-Pacific Etoricoxib Intermediate Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Etoricoxib Intermediate Sales Market Share by Countries 2017
Table Asia-Pacific Etoricoxib Intermediate Revenue by Countries (2013-2018)
Figure Asia-Pacific Etoricoxib Intermediate Revenue Market Share by Countries 2017
Figure China Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Japan Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Korea Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure India Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Southeast Asia Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure South America Etoricoxib Intermediate Revenue and Growth Rate (2013-2018)
Table South America Etoricoxib Intermediate Sales by Countries (2013-2018)
Table South America Etoricoxib Intermediate Sales Market Share by Countries (2013-2018)
Figure South America Etoricoxib Intermediate Sales Market Share by Countries in 2017
Table South America Etoricoxib Intermediate Revenue by Countries (2013-2018)
Table South America Etoricoxib Intermediate Revenue Market Share by Countries (2013-2018)
Figure South America Etoricoxib Intermediate Revenue Market Share by Countries in 2017
Figure Brazil Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Argentina Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Colombia Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Etoricoxib Intermediate Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Etoricoxib Intermediate Sales by Countries (2013-2018)
Table Middle East and Africa Etoricoxib Intermediate Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Etoricoxib Intermediate Sales Market Share by Countries in 2017
Table Middle East and Africa Etoricoxib Intermediate Revenue by Countries (2013-2018)
Table Middle East and Africa Etoricoxib Intermediate Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Etoricoxib Intermediate Revenue Market Share by Countries in 2013
Figure Middle East and Africa Etoricoxib Intermediate Revenue Market Share by Countries in 2017
Figure Saudi Arabia Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure UAE Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Egypt Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure Nigeria Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Figure South Africa Etoricoxib Intermediate Sales and Growth Rate (2013-2018)
Table Global Etoricoxib Intermediate Sales by Type (2013-2018)
Table Global Etoricoxib Intermediate Sales Share by Type (2013-2018)
Table Global Etoricoxib Intermediate Revenue by Type (2013-2018)
Table Global Etoricoxib Intermediate Revenue Share by Type (2013-2018)
Figure Global n-House Manufacturing Sales Growth (2013-2018)
Figure Global n-House Manufacturing Price (2013-2018)
Figure Global Contract Manufacturing Organizations Sales Growth (2013-2018)
Figure Global Contract Manufacturing Organizations Price (2013-2018)
Table Global Etoricoxib Intermediate Sales by Application (2013-2018)
Table Global Etoricoxib Intermediate Sales Share by Application (2013-2018)
Figure Global Psoriatic Arthritis Sales Growth (2013-2018)
Figure Global Osteoarthritis Sales Growth (2013-2018)
Figure Global Ankylosing Spondylitis Sales Growth (2013-2018)
Figure Global Chronic Low Back Pain Sales Growth (2013-2018)
Figure Global Acute Pain Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Etoricoxib Intermediate Sales, Revenue and Growth Rate (2018-2023)
Table Global Etoricoxib Intermediate Sales Forecast by Regions (2018-2023)
Table Global Etoricoxib Intermediate Market Share Forecast by Regions (2018-2023)
Figure North America Sales Etoricoxib Intermediate Market Forecast (2018-2023)
Figure Europe Sales Etoricoxib Intermediate Market Forecast (2018-2023)
Figure Asia-Pacific Sales Etoricoxib Intermediate Market Forecast (2018-2023)
Figure South America Sales Etoricoxib Intermediate Market Forecast (2018-2023)
Figure Middle East and Africa Sales Etoricoxib Intermediate Market Forecast (2018-2023)
Table Global Etoricoxib Intermediate Sales Forecast by Type (2018-2023)
Table Global Etoricoxib Intermediate Market Share Forecast by Type (2018-2023)
Table Global Etoricoxib Intermediate Sales Forecast by Application (2018-2023)
Table Global Etoricoxib Intermediate Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Glycinates Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Oct-2018        Price: US 3480 Onwards        Pages: 137
    Glycine is an amino acid of endogenous antioxidant reductive glutathione. It is often added exogenously in severe stress, sometimes called semi-essential amino acid. Scope of the Report: This report focuses on the Glycinates in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The feed additive segment is ......
  • Global Calming and Sleeping Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 17-Oct-2018        Price: US 3480 Onwards        Pages: 132
    Calming and sleeping products reduce tension and anxiety by inducing sedatives and a hypnotic effect on the body. They act by depressing the central nervous system. Scope of the Report: This report focuses on the Calming and Sleeping in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. They are used to tr......
  • Global Compound Clotrimazole Ointment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Oct-2018        Price: US 3480 Onwards        Pages: 132
    Compound clotrimazole is a broad spectrum anti-fungal agent, which is used for the treatment of dermal infections. The ointment is majorly used for the topical treatment of candidiasis and tinea versicolor pityriasis versicolor. In addition, it is used in the treatment of dermal infections such as Athletes foot, crotch itch, and ringworm. Scope of the Report: This report focuses on the Compound Clotrimazole Ointment in global market, especially in North America, Eur......
  • Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Alpha Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Alpha or Phosphoinositide 3 Kinase Catalytic Alpha Polypeptide or Serine/Threonine Protein Kinase PIK3CA or PIK3CA or EC 2.7.11.1 or EC 2.7.1.153) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 98
    Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Alpha Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Alpha or Phosphoinositide 3 Kinase Catalytic Alpha Polypeptide or Serine/Threonine Protein Kinase PIK3CA or PIK3CA or EC 2.7.11.1 or EC 2.7.1.153) - Pipeline Review, H2 2018 Summary According to the recently published report 'Phosphatidylinositol 4,5 Bisphosphate 3 Kinase - Pipeline Review, H2 2018'; Phosphatidylino......
  • Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 80
    Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2018 Summary According to the recently published report 'Caspase 3 - Pipeline Review, H2 2018'; Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) pipeline Target constitutes close to 13 molecules. Out of which approximately 9 molecules are developed by companies a......
  • Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 56
    Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) pipeline Target constitutes close to 17 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report Glycogen Synthase Kinase 3 Be......
  • Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Analysis 2013-2018 and Forecast 2019-2025
    Published: 16-Oct-2018        Price: US 2900 Onwards        Pages: 133
    This report studies the Chemotherapy Induced Peripheral Neuropathy Treatment market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Chemotherapy Induced Peripheral Neuropathy Treatment market by product type and applications/end industries. In the last several years, global market of Chemotherapy Induced Peripheral Neuropathy Treatment......
  • Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 73
    Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Pipeline Review, H2 2018 Summary According to the recently published report 'Lysosomal Alpha Glucosidase - Pipeline Review, H2 2018'; Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) pipeline Target constitutes close to 16 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes......
  • Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 3500 Onwards        Pages: 69
    Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2018 Summary Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Beta-secretase 1 (BACE1) is an enzyme that in humans is encoded by the BACE1 ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs